Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies : An exploratory analysis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: 10.1002/jgh3.12501

Event: Veröffentlichung

(where): Aachen

(who): Universitätsbibliothek der RWTH Aachen

(when): 2021

Creator: Loosen, Sven
Schulze-Hagen, Max
Vucur, Mihael
Gorgulho, Joao
Paffenholz, Pia
Benz, Fabian
Mohr, Raphael
Demir, Munevver
Wree, Alexander
Kuhl, Christiane
Trautwein, Christian
Tacke, Frank
Bruners, Philipp
Lüdde, Tom
Roderburg, Christoph

DOI: 10.18154/RWTH-CONV-248515

URN: urn:nbn:de:101:1-2023020301262939656200

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:39 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Loosen, Sven
Schulze-Hagen, Max
Vucur, Mihael
Gorgulho, Joao
Paffenholz, Pia
Benz, Fabian
Mohr, Raphael
Demir, Munevver
Wree, Alexander
Kuhl, Christiane
Trautwein, Christian
Tacke, Frank
Bruners, Philipp
Lüdde, Tom
Roderburg, Christoph
Universitätsbibliothek der RWTH Aachen

Time of origin

2021

Other Objects (12)

Hochschulschrift

Untersuchungen zur Rolle microRNA-basierter Regulationsmechanismen in inflammatorischen und fibrotischen Erkrankungen : [kumulative Habilitationsschrift]

Hochschulschrift

Analyse der Dimerisierung des Zytokin-Rezeptors gp130 mit Hilfe von YFP-IL-6, einem funktionellen Fusionsprotein aus Interleukin-6 und dem yellow fluorescent protein

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies

Stride beim fortgeschrittenen oder nicht resezierbaren hepatozellulären Karzinom : erste Erstlinientherapie mit explorativen Daten zum 4-Jahres-Gesamtüberleben

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies

Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies

High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Transarterial Chemoembolization – Status Quo in Germany

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Hochschulschrift

Untersuchungen zur Rolle microRNA-basierter Regulationsmechanismen in inflammatorischen und fibrotischen Erkrankungen : [kumulative Habilitationsschrift]

Hochschulschrift

Analyse der Dimerisierung des Zytokin-Rezeptors gp130 mit Hilfe von YFP-IL-6, einem funktionellen Fusionsprotein aus Interleukin-6 und dem yellow fluorescent protein

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies

Stride beim fortgeschrittenen oder nicht resezierbaren hepatozellulären Karzinom : erste Erstlinientherapie mit explorativen Daten zum 4-Jahres-Gesamtüberleben

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies

Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies

High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Transarterial Chemoembolization – Status Quo in Germany

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Hochschulschrift

Untersuchungen zur Rolle microRNA-basierter Regulationsmechanismen in inflammatorischen und fibrotischen Erkrankungen : [kumulative Habilitationsschrift]

Hochschulschrift

Analyse der Dimerisierung des Zytokin-Rezeptors gp130 mit Hilfe von YFP-IL-6, einem funktionellen Fusionsprotein aus Interleukin-6 und dem yellow fluorescent protein

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies

Stride beim fortgeschrittenen oder nicht resezierbaren hepatozellulären Karzinom : erste Erstlinientherapie mit explorativen Daten zum 4-Jahres-Gesamtüberleben

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies

Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies

High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Transarterial Chemoembolization – Status Quo in Germany

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies : An exploratory analysis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Untersuchungen zur Rolle microRNA-basierter Regulationsmechanismen in inflammatorischen und fibrotischen Erkrankungen : [kumulative Habilitationsschrift]

Analyse der Dimerisierung des Zytokin-Rezeptors gp130 mit Hilfe von YFP-IL-6, einem funktionellen Fusionsprotein aus Interleukin-6 und dem yellow fluorescent protein

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies

Stride beim fortgeschrittenen oder nicht resezierbaren hepatozellulären Karzinom : erste Erstlinientherapie mit explorativen Daten zum 4-Jahres-Gesamtüberleben

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies

Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies

High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Transarterial Chemoembolization – Status Quo in Germany

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Untersuchungen zur Rolle microRNA-basierter Regulationsmechanismen in inflammatorischen und fibrotischen Erkrankungen : [kumulative Habilitationsschrift]

Analyse der Dimerisierung des Zytokin-Rezeptors gp130 mit Hilfe von YFP-IL-6, einem funktionellen Fusionsprotein aus Interleukin-6 und dem yellow fluorescent protein

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies

Stride beim fortgeschrittenen oder nicht resezierbaren hepatozellulären Karzinom : erste Erstlinientherapie mit explorativen Daten zum 4-Jahres-Gesamtüberleben

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies

Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies

High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Transarterial Chemoembolization – Status Quo in Germany

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Untersuchungen zur Rolle microRNA-basierter Regulationsmechanismen in inflammatorischen und fibrotischen Erkrankungen : [kumulative Habilitationsschrift]

Analyse der Dimerisierung des Zytokin-Rezeptors gp130 mit Hilfe von YFP-IL-6, einem funktionellen Fusionsprotein aus Interleukin-6 und dem yellow fluorescent protein

Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies

Stride beim fortgeschrittenen oder nicht resezierbaren hepatozellulären Karzinom : erste Erstlinientherapie mit explorativen Daten zum 4-Jahres-Gesamtüberleben

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies

Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies

High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma

Transarterial Chemoembolization – Status Quo in Germany

Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review

A Changing Role of Transarterial Chemoembolization in the Era of Immune Checkpoint Inhibitor plus Anti-VEGF/TKI plus Transarterial Chemoembolization: From Total Embolization to Partial Embolization (Immune Boost Transarterial Chemoembolization)

Related objects

Reset password